An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Jiangsu Province Hospital, Nanjing, Jiangsu, China
Contact: Principal Investigator (Kuirong Jiang)
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, China
Contact: Principal Investigator (Jihui Hao)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

Pancreatic Cancer · Renal Cell Cancer · Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Phase 2 Study · BMS-986504 · MTAP-deleted Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

Adjustment Disorder · Adjustment Disorder With Anxious Mood · Cancer

Abroad (travel likely)RecruitingPHASE2

Abbotsford, Australia · Northcote, Australia

Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PAC

Pancreas Cancer · Metastatic Pancreatic Cancer · Pancreatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States